Catalyst Pharmaceuticals Inc (CPRX) — Financial Flexibility Index
Catalyst Pharmaceuticals Inc (CPRX) has a Financial Flexibility Index of 0.29x as of December 2025. Free cash flow of $44.92 Million (operating CF $44.89 Million minus capex $32.00K) represents 0% of total liabilities ($152.54 Million). Also explore how fast is Catalyst Pharmaceuticals Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Catalyst Pharmaceuticals Inc Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Catalyst Pharmaceuticals Inc across 22 annual periods. Check CPRX PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Catalyst Pharmaceuticals Inc (2004–2025)
Year-by-year free cash flow to debt coverage for Catalyst Pharmaceuticals Inc. For the full company profile including market capitalisation, see CPRX market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.37x | $208.73 Million | $208.67 Million | $152.54 Million | ▼ -29.5% |
| 2024 | 1.94x | $240.36 Million | $239.81 Million | $123.78 Million | ▼ -29.1% |
| 2023 | 2.74x | $225.34 Million | $143.60 Million | $82.23 Million | ▲ +77.6% |
| 2022 | 1.54x | $116.08 Million | $116.05 Million | $75.21 Million | ▼ -22.2% |
| 2021 | 1.98x | $61.39 Million | $60.37 Million | $30.96 Million | ▲ +0.2% |
| 2020 | 1.98x | $45.05 Million | $45.03 Million | $22.76 Million | ▲ +41.5% |
| 2019 | 1.40x | $34.63 Million | $34.61 Million | $24.75 Million | ▲ +152.8% |
| 2018 | -2.65x | $-25.61 Million | $-25.70 Million | $9.67 Million | ▲ +14.1% |
| 2017 | -3.09x | $-13.65 Million | $-13.74 Million | $4.42 Million | ▲ +58.6% |
| 2016 | -7.45x | $-17.87 Million | $-17.96 Million | $2.40 Million | ▼ -91.6% |
| 2015 | -3.89x | $-17.99 Million | $-18.02 Million | $4.63 Million | ▼ -161.6% |
| 2014 | -1.49x | $-12.88 Million | $-12.94 Million | $8.67 Million | ▲ +40.0% |
| 2013 | -2.48x | $-9.87 Million | $-9.88 Million | $3.98 Million | ▼ -5.6% |
| 2012 | -2.35x | $-5.09 Million | $-5.14 Million | $2.17 Million | ▼ -17.3% |
| 2011 | -2.00x | $-4.98 Million | $-4.99 Million | $2.49 Million | ▲ +83.3% |
| 2010 | -11.97x | $-3.75 Million | $-3.76 Million | $313.71K | ▲ +45.7% |
| 2009 | -22.04x | $-7.68 Million | $-7.68 Million | $348.52K | ▼ -293.0% |
| 2008 | -5.61x | $-8.26 Million | $-8.26 Million | $1.47 Million | ▲ +54.1% |
| 2007 | -12.20x | $-4.36 Million | $-4.42 Million | $357.17K | ▼ -714.9% |
| 2006 | -1.50x | $-1.16 Million | $-1.18 Million | $772.85K | ▼ -13.8% |
| 2005 | -1.32x | $-451.42K | $-455.36K | $342.99K | ▲ +61.0% |
| 2004 | -3.37x | $-228.69K | $-230.52K | $67.80K | — |